Nature Communications (Feb 2021)
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
- Aakriti Gupta,
- Mahesh V. Madhavan,
- Timothy J. Poterucha,
- Ersilia M. DeFilippis,
- Jessica A. Hennessey,
- Bjorn Redfors,
- Christina Eckhardt,
- Behnood Bikdeli,
- Jonathan Platt,
- Ani Nalbandian,
- Pierre Elias,
- Matthew J. Cummings,
- Shayan N. Nouri,
- Matthew Lawlor,
- Lauren S. Ranard,
- Jianhua Li,
- Claudia Boyle,
- Raymond Givens,
- Daniel Brodie,
- Harlan M. Krumholz,
- Gregg W. Stone,
- Sanjum S. Sethi,
- Daniel Burkhoff,
- Nir Uriel,
- Allan Schwartz,
- Martin B. Leon,
- Ajay J. Kirtane,
- Elaine Y. Wan,
- Sahil A. Parikh
Affiliations
- Aakriti Gupta
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Mahesh V. Madhavan
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Timothy J. Poterucha
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Ersilia M. DeFilippis
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Jessica A. Hennessey
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Bjorn Redfors
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Christina Eckhardt
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Behnood Bikdeli
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Jonathan Platt
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Ani Nalbandian
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Pierre Elias
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Matthew J. Cummings
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Shayan N. Nouri
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Matthew Lawlor
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Lauren S. Ranard
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Jianhua Li
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Claudia Boyle
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Raymond Givens
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Daniel Brodie
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Harlan M. Krumholz
- Yale Center for Outcomes Research and Evaluation
- Gregg W. Stone
- Cardiovascular Research Foundation
- Sanjum S. Sethi
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Daniel Burkhoff
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Nir Uriel
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Allan Schwartz
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Martin B. Leon
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Ajay J. Kirtane
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Elaine Y. Wan
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- Sahil A. Parikh
- NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center
- DOI
- https://doi.org/10.1038/s41467-021-21553-1
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 9
Abstract
Statins, which have anti-inflammatory and antithrombotic properties, could have effects in COVID-19 patients. Here, the authors find in a retrospective analysis of patients hospitalized with COVID-19 that antecedent statin use is associated with lower inpatient mortality.
